FDA issued a warning letter this week to a sponsor. Oeyama Moto Medical Foundation was warned for:
- Violating a clinical hold and allowing an investigator to administer investigational product to seven subjects
- Failing to document any monitoring activities
The IRB and investigator for this study have also received warning letters.